| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 1.0K | 3.9% | 1.9% |
| Total Income | 1.0K | 3.9% | 1.9% |
| Expenditure | 845.60 | 6.3% | 6.0% |
| PBT | 170.07 | 14.4% | 79.5% |
| Net Profit | 135.04 | 24.7% | 138.0% |
| OPM | 16.67% | 2.09pp | 7.00pp |
| NPM | 13.31% | 3.06pp | 7.61pp |
| EPS | 1.90 | 25.8% | 143.6% |
Align Technology Announces Third Quarter 2026 Financial Results
29 Oct 2026 · 29 Oct, 1:37 am
Summary
Align Technology reported third quarter 2026 revenues of $1.015 billion, a 1.9% increase year-over-year, driven by a 4.2% rise in Clear Aligner revenues to $839.3 million. The company saw a 6.6% increase in Clear Aligner volume, reaching 690.6 thousand cases. Profitability improved, with the non-GAAP operating margin reaching 24.4%, up 0.5 points year-over-year. Management highlighted continued Clear Aligner growth, expansion of their digital platform, and improved profitability, while also noting a challenging market backdrop for discretionary healthcare spending.
Key Highlights
- 1
Align Technology reported Q3'26 total revenues of $1.015 billion, representing a 1.9% increase year-over-year.
- 2
Clear Aligner revenues for Q3'26 reached $839.3 million, up 4.2% year-over-year, with Clear Aligner volume increasing 6.6% to 690.6 thousand cases.
- 3
Imaging Systems and CAD/CAM Services revenues in Q3'26 were $175.5 million, a decrease of 7.6% year-over-year.
- 4
The company achieved a Q3'26 gross margin of 68.7%, with a non-GAAP gross margin of 70.4%, flat year-over-year.
- 5
Q3'26 operating margin was 16.7%, and the non-GAAP operating margin was 24.4%, an increase of 0.5 points year-over-year.
- 6
Diluted net income per share for Q3'26 was $1.90, compared to $0.78 in Q3'25, with non-GAAP diluted net income per share at $2.80, up from $2.61 in Q3'25.
Management Comments
Joe Hogan
We delivered solid third-quarter results, with Q3 revenues and Clear Aligner volumes in line with our outlook and non-GAAP operating margin was above our prior guidance. Clear Aligner volumes reflect record doctor submitters, record third-quarter Clear Aligner shipments, improved utilization, and broad-based international growth. For the first time in 6 quarters, orthodontist shipments in North America increased year-over-year, and DSO shipments were up double-digits, across both orthodontist and GP customers. Our focus remains on expanding iTero’s reach and in Q3, the number of scanner units placed—including leased, rented and certified pre-owned systems increased double-digits year-over-year, to more than 157,000 systems globally. From a profitability perspective, non-GAAP gross margin was 70.4%, modestly below our expectation, reflecting higher fuel-related transportation costs, lower Clear Aligner ASPs and geographic and product mix. Disciplined expense management and productivity improvements contributed to non-GAAP operating margin of 24.4%, above our outlook. Overall, Q3 demonstrated continued Clear Aligner growth, expansion of our digital platform and customer footprint, and improved profitability. We also have a significant innovation pipeline ahead of us. We continue to be excited about our next-gen direct fabrication 3D printing materials platform, called NXT Technology. NXT Technology unlocks greater control, consistency, and precision across appliance design-enabling an entirely new level of Invisalign® performance and personalization. We are broadening the application of 3D printing across the Invisalign portfolio, as well as expanding into new categories: Invisalign® Specifix attachment system expands our direct 3D-printing capabilities beyond aligners and appliances into the attachment system itself. This week, we will begin a U.S. pilot of a new product Invisalign® Sports Guard -- a custom direct 3D printed sports mouth guards -- made from an iTero™ scan. Sports mouth guards represent a large and growing market opportunity amid increasing awareness of concussion risks in contact sports. There is also significant overlap with our kids and teens demographic, and we expect it to drive awareness and utilization of Invisalign treatment through Invisalign doctors.”
John Morici
I was pleased to deliver third-quarter revenue and Clear Aligner volume in line with our outlook while improving year-over-year profitability. Consistent with our first and second quarters, these results were achieved against a challenging market backdrop, as demand across the dental and orthodontic industry continued to be affected by a softer environment for discretionary healthcare spending and capital equipment investment. Those conditions persisted through the third quarter and our fourth-quarter outlook reflects what we continue to see across the broader market. As we look to 2027, we believe we are positioned to deliver another year of revenue growth and margin expansion. Importantly, our preliminary planning assumes an operating environment broadly consistent with current conditions and does not require a consumer recovery.
Informational and educational content only. Not investment advice.